Oscar Santes1, Enrique Coss-Adame2, Miguel A Valdovinos2, Janette Furuzawa-Carballeda3, Angélica Rodríguez-Garcés4, Jose Peralta-Figueroa4, Sofia Narvaez-Chavez4, Hector Olvera-Prado4, Uriel Clemente-Gutiérrez1, Gonzalo Torres-Villalobos5,6. 1. Department of Surgery, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico. 2. Department of Gastroenterology, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico. 3. Department of Immunology and Rheumatology, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico. 4. Department of Experimental Surgery, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico. 5. Department of Surgery, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico. torresvgm@yahoo.com.mx. 6. Department of Experimental Surgery, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico. torresvgm@yahoo.com.mx.
Abstract
BACKGROUND: Laparoscopic Heller myotomy fails in approximately 3.5% to 15% of patients. Evidence of successful laparoscopic reoperation is limited to a few studies. METHODS: This case-control study was conducted in patients who underwent laparoscopic Heller myotomy reoperation (LHM-R) from 2008 to 2016. The operative outcomes, preoperative and last follow-up manometric parameters, and symptom questionnaire results, including the Eckardt, Gastroesophageal Reflux Disease-Health Related Quality of Life (GERD-HRQL) and eating assessment tool (EAT-10) scores, were obtained. The data were compared with those of patients who underwent primary laparoscopic Heller myotomy (LHM-1). RESULTS: Thirty-five patients who underwent LHM-R and 35 patients who underwent LHM-1 were included. The reasons for failure in the LHM-R patient group included incomplete myotomy (71.4%), myotomy fibrosis (25.7%) and structural alterations in fundoplication (2.9%). The follow-up duration was 34 months for the LHM-R group and 24 months for the LHM-1 group (p = 0.557). The procedure was performed by laparoscopy in 100% of the patients in the two groups. No differences were found regarding surgical morbidity (11.4% LHM-R vs. 2.9% LHM-1, p = 0.164). The symptomatic outcomes were equivalent between groups (Eckardt p = 0.063, EAT-10 p = 0.166, GERD-HRQL p = 0.075). An IRP < 15 mmHg was achieved in 100% of the LHM-R and LHM-1 patients. At the last follow-up, 82.1% of the LHM-R patients and 91.4% of the LHM-1 patients were in symptomatic remission (p = 0.271). CONCLUSION: The results achieved with LHM-R are similar to those achieved with LHM-1. Laparoscopic reoperation should be considered an effective and safe treatment after a failed Heller myotomy.
BACKGROUND: Laparoscopic Heller myotomy fails in approximately 3.5% to 15% of patients. Evidence of successful laparoscopic reoperation is limited to a few studies. METHODS: This case-control study was conducted in patients who underwent laparoscopic Heller myotomy reoperation (LHM-R) from 2008 to 2016. The operative outcomes, preoperative and last follow-up manometric parameters, and symptom questionnaire results, including the Eckardt, Gastroesophageal Reflux Disease-Health Related Quality of Life (GERD-HRQL) and eating assessment tool (EAT-10) scores, were obtained. The data were compared with those of patients who underwent primary laparoscopic Heller myotomy (LHM-1). RESULTS: Thirty-five patients who underwent LHM-R and 35 patients who underwent LHM-1 were included. The reasons for failure in the LHM-R patient group included incomplete myotomy (71.4%), myotomy fibrosis (25.7%) and structural alterations in fundoplication (2.9%). The follow-up duration was 34 months for the LHM-R group and 24 months for the LHM-1 group (p = 0.557). The procedure was performed by laparoscopy in 100% of the patients in the two groups. No differences were found regarding surgical morbidity (11.4% LHM-R vs. 2.9% LHM-1, p = 0.164). The symptomatic outcomes were equivalent between groups (Eckardt p = 0.063, EAT-10 p = 0.166, GERD-HRQL p = 0.075). An IRP < 15 mmHg was achieved in 100% of the LHM-R and LHM-1 patients. At the last follow-up, 82.1% of the LHM-R patients and 91.4% of the LHM-1 patients were in symptomatic remission (p = 0.271). CONCLUSION: The results achieved with LHM-R are similar to those achieved with LHM-1. Laparoscopic reoperation should be considered an effective and safe treatment after a failed Heller myotomy.
Authors: Gianluca Rossetti; Luigi Brusciano; Giuseppe Amato; Vincenzo Maffettone; Vincenzo Napolitano; Gianluca Russo; Domenico Izzo; Federica Russo; Francesco Pizza; Gianmattia Del Genio; Alberto Del Genio Journal: Ann Surg Date: 2005-04 Impact factor: 12.969
Authors: Angeles Ortiz; Luisa F Martinez de Haro; Pascual Parrilla; Ana Lage; Domingo Perez; Vicente Munitiz; David Ruiz; Joaquín Molina Journal: Ann Surg Date: 2008-02 Impact factor: 12.969
Authors: Louis O Jeansonne; Brent C White; Kelly E Pilger; Matthew D Shane; Stanley Zagorski; S Scott Davis; John G Hunter; Edward Lin; C Daniel Smith Journal: Surg Endosc Date: 2007-07-11 Impact factor: 4.584
Authors: Sarah M Cowgill; Desiree Villadolid; Robert Boyle; Sam Al-Saadi; Sharona Ross; Alexander S Rosemurgy Journal: Surg Endosc Date: 2009-06-24 Impact factor: 4.584
Authors: Janette Furuzawa-Carballeda; Joaquín Zuñiga; Diana I Hernández-Zaragoza; Rodrigo Barquera; Eduardo Marques-García; Luis Jiménez-Alvarez; Alfredo Cruz-Lagunas; Gustavo Ramírez; Nora E Regino; Ramón Espinosa-Soto; Edmond J Yunis; Fernanda Romero-Hernández; Daniel Azamar-Llamas; Enrique Coss-Adame; Miguel A Valdovinos; Samuel Torres-Landa; Axel Palacios-Ramírez; Blanca Breña; Edgar Alejandro-Medrano; Axel Hernández-Ávila; Julio Granados; Gonzalo Torres-Villalobos Journal: PLoS One Date: 2018-08-09 Impact factor: 3.240
Authors: Janette Furuzawa-Carballeda; Samuel Torres-Landa; Miguel Ángel Valdovinos; Enrique Coss-Adame; Luis A Martín Del Campo; Gonzalo Torres-Villalobos Journal: World J Gastroenterol Date: 2016-09-21 Impact factor: 5.742
Authors: Antonio Cubisino; Francisco Schlottmann; Nicolas H Dreifuss; Carolina Baz; Alberto Mangano; Mario A Masrur; Francesco M Bianco; Pier Cristoforo Giulianotti Journal: Langenbecks Arch Surg Date: 2022-05-18 Impact factor: 2.895